I honored to serve as Editor-in-Chief for JCO Oncology Advances! To learn more, please read my editorial: https://t.co/bdnGXIApUG @ASCO @JCO_ASCO @YaleCancer @SmilowCancer @YaleMed

I think a big problem here is that medical school only exposes people to inpatient oncology, which is a wildly different (and sadder) world from outpatient oncology- which is like 90% of cancer care. So students have an incorrect idea of what practicing oncology is like.

Connect your apps to AI on your terms. Introducing Turbo MCP, our enterprise-friendly, self-hosted MCP security platform and connectivity gateway. If you're looking to bring AI productivity to your workplace, Turbo MCP was designed with partners in highly-regulated industries,

The editors of @JCO_ASCO recently met at the @ASCO headquarters to discuss strategy and planning for the year ahead. @PamelaKunzMD serves as editor-in-chief and was joined by associate editors, including Yale’s @maryam_lustberg. @SmilowCancer @YNHH

Terrific commentary from @gagan_brar24 @cityofhope w mentorship from @aparna1024 @MGHCancerCenter on a recent manuscript in @JCOOA_ASCO assessing use of ctDNA in #Vietnam. Full paper here: https://t.co/eqQlIS18u1

Congrats, Eliot! #ProudMom ⚾️👏

🚨 Hot off the press in @ASCO journal @JCOOA_ASCO 👉Pleased to share our study 👉 "Impact of FDA Project Optimus Guidance on Design of Early-Phase Clinical Trials" 📊 Analysis of 367 phase I #oncology trials (2021-2024) reveals Project Optimus is transforming cancer drug

Great energy at our 1st @JCOOA_ASCO editors meeting at @ASCO HQ. Proud to advance cancer research, and support rapid, impactful publication. Submit your Brief Reports, Phase I/II Trials, Trials in Progress & more.. #JCOOA #CancerResearch #Oncology @PamelaKunzMD

Raghav Sundar Talking with Dr Eric Weiner Director Yale Cancer Center on advances in Gastroesophageal Cancers @sundar__raghav @DrEricWiner @PamelaKunzMD @YaleCancer @SmilowCancer @somusp9 @RRPillarisetti @Jasonphilip8 @karthik2k2 @arvindcanchi @VijayKher8 @Geeky_Foodie

Thanks, Taymeyah! I had lots of fun doing this podcast with you. You are a great interviewer!

Was so fun to film this conversation with the amazing @PamelaKunzMD ! Give it a listen and follow @Taytalks_pod to get more! We’ve got 7 episodes up so far!

I'll be participating in the Closer to Free Ride on Saturday, September 6th in honor of my patients with GI Cancers / Neuroendocrine tumors. Please consider supporting me to raise funds to support our research. 🙏🚴‍♀️ https://t.co/VBkiGOqmCh

For every kiddo who has felt a little different in the classroom, @BKaplan12 and I co-wrote this book to help them know it’s ok to need some extra help! Illustrated by Avery Stern. @IngramPubPros @MoWillems #HazeltheChicken #SpEd #speced #childrensbooks

@jordanberlin5 Thank you Jordan for always advocating for mentorship, growing the pipeline and increasing diversity at the podium!!! @PamelaKunzMD

❗️MUTYH mutant #pancreatic #NET (germline/somatic) ✅3% ✅50% second hit genetic event ✅2/3 G1/2 evolved to G3 ✅3/7 tumors molecularly profiled after alkylating drugs and/or PRRT had high TMB ✅ aggressive , high-grade disease when metastatic @TAMedOncol @gitorrezan

Submit your abstracts and plan to join us in SF for @ASCO #GI26! We are planning a program to address both scientific and practical challenges, as we move toward conquering cancer.

It was such an honor to help tell Anthony's story with help from the amazing 'Medical Stories' team. We hope this docuseries raises awareness about neuroendocrine tumors. Watch on your local @PBS station, YouTube, or the link below.👇🦓

Great piece on the importance of maintaining, not cutting, federal funding of research. Millions of people have benefitted from the research supported by federal dollars.

‼️ #ASCO25 #JCOOA simultaneous publication by O'Neill et al:  Implementation of a Medication Reconciliation Televisit Model in Phase I Oncology Clinical Trials. Read the full article: https://t.co/7aR00vtNNp @PamelaKunzMD

Don't miss this CME webinar on my favorite topic - Neuroendocrine Cancers! 🦓 ⬇️